InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.71
(
-0.24%
)
Bitcoin
58,844.41
(
-2.19%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rocketeer357

Send PM Follow Ignore
Followers 32
Posts 3548
Boards Moderated 0
Alias Born 07/02/2004

rocketeer357

Re: trade2much post# 70507

Friday, 08/09/2013 4:12:11 AM

Friday, August 09, 2013 4:12:11 AM

Post# of 97239
MACK

from Mike Havrilla: The major risk factor for MACK includes expected failure for several Phase II clinical trials for MM-121 as previously reported and updated in the recent prospectus filing. I believe this is mostly a headline risk since most of the bad news should already be reflected in stock unless the drug fails in every ongoing Phase II trial.

This is a stock which needs little reason to get beat up any more, but it sounds like more reasons might be a comin'.....
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up